At present, there are more and more mature studies in breast cancer, and the molecular biological indicators widely used in clinic include ER, PR, and HER-2, which are closely related to the occurrence, development, diagnosis, treatment and prognosis of breast cancer. This evidence concerns the gene ERBB2 and breast cancer.